Danaher’s Cepheid Acquisition Receives Required Regulatory Clearances
News Oct 24, 2016
Clearances received or waiting periods expired in the United States, Germany, Austria and South Africa, which comprise all of the governmental approvals required as a closing condition pursuant to the merger agreement executed in connection with the proposed acquisition of Cepheid by Danaher Corporation.
Cepheid is scheduled to hold a special meeting of its shareholders on November 4, 2016 to consider and vote upon the approval of the Merger.
New Microfluidic Chip Boosts the Sensitivity of Immunoassays by >1000xNews
The chip works well even when protein biomarkers are present in extremely small numbers, as is the situation during the early stages of a disease.READ MORE
UVA Health Enlists Robotic Help to Enhance Blood TestingNews
The system has revolutionized how it tests patient blood samples, automating its primary testing facility with high-tech robots that are getting doctors the results they need quickly and efficiently – and allowing UVA to offer a wider range of blood tests, to boot.